# EchoNous

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/echonous

- Industry: Medical Devices & Equipment
- Headquarters: Redmond, US
- Website: www.echonous.com
- Total disclosed funding: $44M
- Latest round: Series B (Sep 28, 2017)
- Investors on record: 4

## About

EchoNous, Inc. develops innovative Point-of-Care Ultrasound (POCUS) technology, focusing on enhancing clinical assessments through AI-driven imaging solutions for healthcare professionals.Founded in 2016 and headquartered in Redmond, US, EchoNous, Inc. specializes in Point-of-Care Ultrasound technology. The company was founded by Neil Bartlett, who has a history of successful ventures in medical technology. EchoNous has closed 9 deals, with its most recent funding round, Series D, occurring on June 28, 2023, where it raised USD 7.000 mn from Kennedy Lewis Investment Management, bringing the total amount raised to USD 7.000 mn and the current company valuation to USD 53.396 mn.EchoNous Inc. specializes in advanced Point-of-Care Ultrasound (POCUS) technology, particularly with its flagship product, the Kosmos Bladder scanner. This device, powered by artificial intelligence, provides accurate imaging for bladder assessments and is versatile enough to function in various clinical settings. It assists both novice and experienced clinicians in assessing cardiac, pulmonary, and abdominal conditions, and is marketed primarily to healthcare providers across North America, Europe, and Asia, including hospitals, emergency departments, and primary care facilities.EchoNous operates a revenue model based on direct sales to healthcare institutions, focusing on B2B transactions. Its revenue stems from the sale of the Kosmos product line, including the Kosmos Bladder scanner and supplementary transducers, alongside software solutions that enhance imaging capabilities. The complete Kosmos system, which includes a medical-grade stand and AI features on a 13-inch Apple iPad®, is priced below USD 21,000, while the Kosmos Mobile solution, equipped with an Apple iPad Air or Pro® and advanced Doppler features, is offered for under USD 12,000.In June 2023, EchoNous, Inc. raised USD 7.000 mn in venture funding, which will be utilized to support the development of new products and expand into additional markets. The company is focused on enhancing its existing product line and exploring new geographic regions to better serve healthcare providers. Specific markets for expansion have not been disclosed, but the recent funding is expected to facilitate these growth initiatives.

## Funding rounds

- Series B, Sep 28, 2017, $35M — KKR
- Series B, Mar 30, 2010, $5M — Brandon Capital Partners, Playford Capital, Southmore Capital
- Series A, Jul 21, 2009, $4M — Brandon Capital Partners, Playford Capital, Southmore Capital

## Investors

- Brandon Capital Partners (https://capitalatlas.ai/funds/brandon-capital-partners) — Series A, Series B
- Playford Capital (https://capitalatlas.ai/funds/playford-capital) — Series A, Series B
- Southmore Capital (https://capitalatlas.ai/funds/southmore-capital) — Series A, Series B
- KKR (https://capitalatlas.ai/funds/kkr) — Series B